Trial Profile
An Open-Label Trial of Duloxetine for the Treatment of Irritable Bowel Syndrome Without Comorbid Major Depressive Disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 08 Sep 2010 New trial record